VIEMED HEALTHCARE, INC. Cash and Equivalents

Quick Answer

VIEMED HEALTHCARE, INC. reported Cash and Equivalents of $13.50 million for fiscal year 2025.

VIEMED HEALTHCARE, INC. Cash and Equivalents — Annual History

Fiscal Year Cash and Equivalents YoY Change
2025 $13.50M -23.0%
2024 $17.54M +36.6%
2023 $12.84M -24.1%
2022 $16.91M -40.5%
2021 $28.41M -8.3%
2020 $30.98M +132.0%
2019 $13.36M +5.7%
2019 $12.63M +64.2%
2019 $7.69M +3.8%
2019 $7.41M -28.8%
2018 $10.41M +2.3%
2018 $10.17M +19.0%
2018 $8.55M +84.5%
2018 $4.63M

Quarterly Cash and Equivalents

Quarter Ending Cash and Equivalents YoY QoQ
September 30, 2025 $11.12M -2.0% -44.4%
June 30, 2025 $20.02M +127.3% +97.0%
March 31, 2025 $10.16M +39.0% -42.1%
December 31, 2024 $17.54M +36.6% +54.6%
September 30, 2024 $11.35M +12.6% +28.8%
June 30, 2024 $8.81M -13.9% +20.5%
March 31, 2024 $7.31M -69.0% -43.1%
December 31, 2023 $12.84M -24.1% +27.4%
  • VIEMED HEALTHCARE, INC. showed a decrease of -23.0% in Cash and Equivalents compared to the prior fiscal year.
  • Over the 2018–2025 period, VIEMED HEALTHCARE, INC.’s cash and equivalents has grown by 191.3% (from $4.63 million to $13.50 million).
  • The most recent figure is from VIEMED HEALTHCARE, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment